Weekly Spotlight - 21.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Sage Therapeutics Stock Plummets After Failed Trial of New Treatment for Neurodegenerative Condition

Sage Therapeutics' stock dropped after their trial for a huntington's disease treatment failed. The company announced it will stop the trial, disappointing hopes for a new treatment for the debilitating genetic disorder. This setback affects patients and families looking for effective treatments for huntington's disease.

Gene Linked to Early Brain Changes in Huntington's Patients Discovered

Researchers have discovered that the gene responsible for Huntington's disease starts affecting the brain much earlier than previously thought, even before symptoms appear. This finding could lead to new strategies for early intervention and treatment of the disease.

Coping Strategies for Mental Health in Patients with HD: Practical Tips for Better Living

The article discusses mental health coping strategies for individuals living with Huntington's disease. It highlights the importance of managing stress, seeking support from family and friends, and engaging in activities that promote well-being. The strategies aim to improve quality of life and emotional resilience for those affected by Huntington's disease.

New Drug Shows Promise in Slowing Down Cognitive Decline in Patients

The article discusses a new study on huntington's disease, focusing on the potential of a drug called AMX0035 to slow down the progression of the disease. It explains how the drug works and the promising results from clinical trials, offering hope for those affected by huntington's disease.